Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other
companies in this sector in the United States:
sales of $20.41 billion
of which 34%
Eli Lilly and Company
of which 35%
was Endocrinology), and
Bristol-Myers Squibb Company
of which 100%
Teva Pharmaceutical Industries Limited reported sales of $19.65 billion
December of 2015.
decrease of 3.1%
versus 2014, when the company's sales were $20.27 billion.
Contributing to the drop in overall sales was the 2.7% decline
in Generic Madicines, from $9.81 billion to $9.55 billion.
There were also decreases in sales in
Specialty Medicines (down 2.6% to $8.34 billion)